Silverarc Capital Management LLC erwarb Anteile der Scholar Rock Holding Co. Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.

Silverarc Capital Management LLC kaufte im dritten Quartal 9.711 Aktien der Scholar Rock Holding Co. (NASDAQ:SRRK) für eine Investition von 69.000 US-Dollar. Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. Auch andere Investoren wie die Royal Bank of Canada und die Amalgamated Bank erhöhten ihre Anteile an SRRK. Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc ist an verschiedenen Biotech-Unternehmen beteiligt, darunter Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics und Viridian Therapeutics. Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.